• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白去乙酰化酶抑制剂联合血管紧张素转化酶抑制剂对宫颈癌的转录组学影响

Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma.

机构信息

Unidad de Investigación Biomédica en Cáncer, Instituto de Investigaciones Biomédicas (IIB), Universidad Nacional Autonóma de Mexico (UNAM), Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.

出版信息

Oncol Rep. 2011 Feb;25(2):399-407. doi: 10.3892/or.2010.1086. Epub 2010 Dec 8.

DOI:10.3892/or.2010.1086
PMID:21152880
Abstract

Aberrant DNA methylation and histone deacetylation participate in cancer development and progression; hence, their reversal by inhibitors of DNA methylation and histone deacetylases is a promising cancer therapy. Experimental data demonstrate that these inhibitors in combination do not only show synergy in antitumor effects but also in whole genome global expression. Ten pairs of pre- and post-treatment cervical tumor samples were analyzed by microarray analysis. Treatment for seven days with hydralazine and valproate (HV) in patients up-regulated 964 genes. The two pathways possessing the highest number of up-regulated genes comprised the ribosome protein and the oxidative phosphorylation pathways, followed by MAPK signaling, tight junction, adherens junction, actin cytoskeleton, cell cycle, focal adhesion, apoptosis, proteasome, Wnt signaling, and antigen processing and presentation pathways. Up-regulated genes by HV, clustered with down-regulated genes in untreated primary cervical carcinomas and were more alike as compared with up-regulated genes from untreated patients in terms of gene ontology. Increased acetylated p53 was also observed. Epigenetic therapy with HV leads to gene reactivation in primary tumors of cervical cancer patients as well as protein acetylation. A number of these reactivated genes have a definitive role as a tumor suppressors. The global expression pattern induced by HV suggests this therapy has an impact on pathways related to energy production which may promote apoptosis.

摘要

异常的 DNA 甲基化和组蛋白去乙酰化参与癌症的发生和发展;因此,通过 DNA 甲基化抑制剂和组蛋白去乙酰化酶抑制剂将其逆转是一种很有前途的癌症治疗方法。实验数据表明,这些抑制剂联合使用不仅在抗肿瘤作用方面具有协同作用,而且在全基因组的整体表达方面也具有协同作用。通过微阵列分析,对 10 对治疗前后的宫颈肿瘤样本进行了分析。用肼屈嗪和丙戊酸钠(HV)对患者进行为期 7 天的治疗,上调了 964 个基因。两条途径拥有最多上调的基因,包括核糖体蛋白和氧化磷酸化途径,其次是 MAPK 信号转导、紧密连接、黏着连接、肌动蛋白细胞骨架、细胞周期、焦点黏附、细胞凋亡、蛋白酶体、Wnt 信号转导和抗原处理和呈递途径。HV 上调的基因与未经处理的原发性宫颈癌中的下调基因聚类,与未经处理的患者相比,HV 上调的基因在基因本体论方面更相似。还观察到乙酰化 p53 的增加。用 HV 进行表观遗传治疗可导致宫颈癌患者的原发性肿瘤基因重新激活和蛋白质乙酰化。许多这些重新激活的基因具有作为肿瘤抑制因子的明确作用。HV 诱导的整体表达模式表明,这种治疗方法对与能量产生相关的途径有影响,可能促进细胞凋亡。

相似文献

1
Transcriptional changes induced by epigenetic therapy with hydralazine and magnesium valproate in cervical carcinoma.组蛋白去乙酰化酶抑制剂联合血管紧张素转化酶抑制剂对宫颈癌的转录组学影响
Oncol Rep. 2011 Feb;25(2):399-407. doi: 10.3892/or.2010.1086. Epub 2010 Dec 8.
2
The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study.DNA甲基化和组蛋白去乙酰化酶抑制剂对宫颈癌中人乳头瘤病毒早期基因表达的影响:一项体外和临床研究
Virol J. 2007 Feb 26;4:18. doi: 10.1186/1743-422X-4-18.
3
A proof-of-principle study of epigenetic therapy added to neoadjuvant doxorubicin cyclophosphamide for locally advanced breast cancer.一项关于表观遗传学治疗联合新辅助多柔比星环磷酰胺治疗局部晚期乳腺癌的原理验证研究。
PLoS One. 2006 Dec 20;1(1):e98. doi: 10.1371/journal.pone.0000098.
4
Hydralazine-valproate: a repositioned drug combination for the epigenetic therapy of cancer.肼屈嗪-丙戊酸盐:一种用于癌症表观遗传治疗的重新定位的药物组合。
Expert Opin Drug Metab Toxicol. 2014 Oct;10(10):1433-44. doi: 10.1517/17425255.2014.947263. Epub 2014 Aug 25.
5
Epigenome: a new target in cancer therapy.表观基因组:癌症治疗的新靶点。
Clin Ter. 2008 Sep-Oct;159(5):347-60.
6
Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer.对表观遗传修饰的药理学抑制,结合基因表达谱分析,揭示了肺癌中异常DNA甲基化和组蛋白去乙酰化的新靶点。
Oncogene. 2007 Apr 19;26(18):2621-34. doi: 10.1038/sj.onc.1210041. Epub 2006 Oct 9.
7
Valproic acid as epigenetic cancer drug: preclinical, clinical and transcriptional effects on solid tumors.丙戊酸作为表观遗传癌症药物:对实体瘤的临床前、临床及转录效应
Cancer Treat Rev. 2008 May;34(3):206-22. doi: 10.1016/j.ctrv.2007.11.003. Epub 2008 Jan 15.
8
Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression.肼苯哒嗪与APC去甲基化和重新表达相关,在体外抑制人宫颈癌细胞生长。
Cancer Chemother Pharmacol. 2009 Mar;63(4):605-13. doi: 10.1007/s00280-008-0773-z. Epub 2008 Jun 3.
9
Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.表观遗传药物作为癌症治疗中的多效性药物:生物分子方面及临床应用
J Cell Physiol. 2007 Aug;212(2):330-44. doi: 10.1002/jcp.21066.
10
Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.血液系统恶性肿瘤中的表观遗传靶点:HDAC抑制剂与去甲基化剂的联合疗法
Expert Rev Anticancer Ther. 2007 Oct;7(10):1439-49. doi: 10.1586/14737140.7.10.1439.

引用本文的文献

1
Drug-Induced Renal Vasculitis: Etiology, Pathogenesis, Clinical Manifestations, and Therapeutic Approaches-A Narrative Review.药物性肾血管炎:病因、发病机制、临床表现及治疗方法——一篇叙述性综述
Health Sci Rep. 2025 Apr 16;8(4):e70667. doi: 10.1002/hsr2.70667. eCollection 2025 Apr.
2
Micro- and Macronutrients in Endometrial Cancer-From Metallomic Analysis to Improvements in Treatment Strategies.子宫内膜癌中的微量和常量营养素 - 从金属组学分析到改善治疗策略。
Int J Mol Sci. 2024 Sep 14;25(18):9918. doi: 10.3390/ijms25189918.
3
A Rare Case of Hydralazine-Induced Diffuse Alveolar Hemorrhage.
1例罕见的肼屈嗪诱发弥漫性肺泡出血病例。
Cureus. 2023 Oct 24;15(10):e47591. doi: 10.7759/cureus.47591. eCollection 2023 Oct.
4
The Emerging Role of Histone Deacetylase Inhibitors in Cervical Cancer Therapy.组蛋白去乙酰化酶抑制剂在宫颈癌治疗中的新兴作用
Cancers (Basel). 2023 Apr 10;15(8):2222. doi: 10.3390/cancers15082222.
5
Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines.肼屈嗪和帕比司他可减轻前列腺癌细胞系的恶性特性。
Pharmaceuticals (Basel). 2021 Jul 13;14(7):670. doi: 10.3390/ph14070670.
6
Changes in the in vitro activity of platinum drugs when administered in two aliquots.分两次给药时铂类药物体外活性的变化。
BMC Cancer. 2016 Aug 26;16(1):688. doi: 10.1186/s12885-016-2731-1.
7
Serine/threonine kinases 31(STK31) may be a novel cellular target gene for the HPV16 oncogene E7 with potential as a DNA hypomethylation biomarker in cervical cancer.丝氨酸/苏氨酸激酶31(STK31)可能是HPV16癌基因E7的一个新型细胞靶基因,有潜力作为宫颈癌中DNA低甲基化生物标志物。
Virol J. 2016 Apr 5;13:60. doi: 10.1186/s12985-016-0515-5.
8
The mechanism of hydralazine-induced collagen biosynthesis in cultured fibroblasts.肼屈嗪诱导培养成纤维细胞胶原生物合成的机制。
Naunyn Schmiedebergs Arch Pharmacol. 2013 Apr;386(4):303-9. doi: 10.1007/s00210-013-0836-5. Epub 2013 Jan 24.
9
DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells.水合肼通过 DNA 甲基化非依赖性途径逆转宫颈癌 gemcitabine 耐药。
PLoS One. 2012;7(3):e29181. doi: 10.1371/journal.pone.0029181. Epub 2012 Mar 12.